Quick Answer: A private-label cosmetic is not exempt from EU cosmetic rules because a supplier has made the formula before. Before placing the final branded product on the EU market, identify an EU-established Responsible Person (RP), confirm the exact formula and packaging, complete the safety assessment and Product Information File (PIF), approve compliant labels and claims, and submit the required CPNP notification. Match every document to the product actually sold; do not rely on a generic supplier “EU certificate.”
Who is this Europe private-label checklist for?
This checklist is for beauty brands, importers and distributors purchasing ready-developed or customised cosmetics from an OEM/ODM manufacturer for sale in the European Union. It is a launch-control tool, not a claim that one document or portal entry equals approval. Regulation (EC) No 1223/2009 applies to the product as marketed. A previous formula dossier can be valuable evidence, but it must be checked against your actual branded version, pack, claims and intended use.
The pre-launch compliance checklist
| Gate | Evidence or action to verify | Owner of final sign-off |
|---|---|---|
| 1. Product identity | Final formula/version, intended use, shade or fragrance variants, packaging and markets | Brand + EU RP |
| 2. EU Responsible Person | Named EU-established RP; written appointment where needed | Importer / brand + RP |
| 3. Ingredient review | Restrictions, prohibited substances and relevant annexes checked for final formula | RP + assessor |
| 4. Safety assessment | Product-specific CPSR signed by qualified assessor before placement | RP + assessor |
| 5. PIF | Article 11 file complete and available at labelled RP address | RP |
| 6. GMP | Manufacturing method and GMP statement/evidence | Manufacturer supplies; RP verifies |
| 7. Label and claims | Article 19 particulars, market language and substantiated claims | Brand + RP |
| 8. CPNP | Article 13 information matches the finished marketed product | RP; defined distributor cases separately |
| 9. Release and change control | Final pack, batch, documentation and notification aligned | Brand + RP |
1. Identify the EU Responsible Person before ordering
Article 4 of the EU Cosmetics Regulation requires an RP established within the Union. For an imported cosmetic, the importer is the RP for the product unless another EU-established person is designated by written mandate and accepts in writing under the Regulation. A brand name on the label is not by itself proof of an RP arrangement. Put the named person, product scope, file access and change-notification process in the contract.
Do not assume a non-EU manufacturer becomes the RP because it offers a “CPNP service.” The supplier can support data collection, but the RP has its own Article 5 duties. See our manufacturer-versus-RP explanation for a practical handover model.
2. Freeze the exact private-label product
Request the final formula and INCI ingredient information, product specification, intended consumer/use, final packaging materials, artwork and claims. A supplier’s base formula may change when the brand chooses a fragrance, colour, active ingredient, pack or market claim. Keep a version-controlled product specification. Tell the assessor and RP about all planned variants rather than assuming one prior safety report covers them.
The RP and assessor should check applicable restrictions and annexes against the final ingredient list. For a focused review, use our EU ingredient-check guide. The manufacturer should disclose data to authorised compliance parties through an agreed confidentiality process; a marketing-level INCI list alone may not be enough for safety assessment.
3. Complete the CPSR and Product Information File
Article 10 requires a safety assessment and CPSR before market placement; Annex I describes the report information. The Commission’s CPSR guidelines help explain its format. The qualified assessor evaluates the final product evidence, including composition, exposure, stability, microbiological quality and packaging where relevant. The assessment is not just a supplier certificate.
Article 11 requires the RP to keep a PIF available at the address indicated on the label. It includes a clear product description, CPSR, description of manufacturing and a GMP statement, substantiation of claimed effects where justified, and relevant animal-testing data. Ask the supplier for the underlying manufacturing and quality records, then have the RP confirm the file is complete and maintainable. Our CPSR guide and CPNP/CPSR/PIF comparison cover these separate roles.
4. Verify GMP, labels and product claims
Article 8 requires manufacturing in accordance with good manufacturing practice. The European Commission lists EN ISO 22716:2007 among cosmetics harmonised standards. Ask the manufacturer what GMP evidence applies to the actual production site and product; a certificate alone does not replace the product safety assessment.
Article 19 specifies labelling particulars. Check the RP’s name and address, nominal content, durability or period-after-opening information as applicable, precautions, batch number, product function where needed and ingredient list, with the Regulation’s specific conditions. The responsible team should also review required language for the destination markets and packaging constraints. Article 20 and the EU claims framework require supported, non-misleading claims; avoid medicinal promises that could change product classification. See our EU claims guide.
| Private-label change | Question to ask before reusing supplier evidence | Potential consequence |
|---|---|---|
| New brand name only | Does product identification and notification reflect the new name? | Update product and portal records as required |
| New fragrance or shade | Does the CPSR cover the variant and its ingredient exposure? | Further assessment or evidence may be needed |
| New packaging or applicator | Does compatibility and use evidence match the final pack? | Review CPSR/PIF and artwork |
| Different claims | Are effects substantiated and the product still a cosmetic? | Revise label, substantiation or classification |
| New EU destination market | Does the label meet applicable language and distribution needs? | Market-specific artwork review |
5. Notify via CPNP and check the final release
Article 13 sets the RP’s CPNP notification duties before placing a cosmetic on the EU market. The European Commission CPNP portal is free of charge. Certain distributors have additional notification duties in defined situations. Do not describe CPNP as an approval, certificate or substitute for the CPSR and PIF. The final entry, artwork and sold product must tell the same story.
For release, have the brand and RP compare the production specification and batch, label artwork, claims, CPSR version, PIF inventory and CPNP data. Record who approved each gate and where the evidence is stored. Establish a path for formula changes, complaints, serious undesirable effects and recalls where applicable. A launch date and budget should come from actual evidence gaps, not a generic promise; see our separate timeline and cost guides.
What should the manufacturer and brand each provide?
A manufacturer can provide final formula and INCI data to authorised assessors, raw-material specifications, COAs, relevant SDSs, manufacturing method and GMP records, finished-product specifications, available stability and microbiological reports, packaging-compatibility data and batch documentation. The brand defines the final commercial product, claims, artwork and destination markets, appoints or identifies the RP, and funds any missing work under its supplier contracts. The RP and safety assessor perform their regulatory and professional roles. A written responsibility matrix keeps the handover auditable.
Frequently asked questions
Is a private-label cosmetic automatically EU compliant if the supplier sold it before?
No. The RP must verify the final branded formula, packaging, label, claims and documents for the version being placed on the market.
Is CPNP a cosmetic approval certificate?
No. CPNP is a notification portal. Product safety assessment, PIF and other applicable obligations remain necessary.
Can a non-EU manufacturer hold the PIF instead of the RP?
The manufacturer can provide source documents, but Article 11 requires the PIF to be available through the EU RP at the address indicated on the label.
Does one CPSR cover all private-label variants?
Do not assume that. The qualified assessor and RP must verify the report’s scope against each final variant and package.
Official sources and review
Regulation (EC) No 1223/2009; European Commission CPSR guidance; European Commission CPNP; Cosmetics harmonised standards. Last reviewed: 28 September 2026. Editorial preparation: MOOYAM cosmetic compliance content team. Regulatory requirements and commercial handover suggestions are distinguished; this checklist is not legal advice.
MOOYAM provides cosmetic OEM/ODM manufacturing and technical-documentation support for international beauty brands. To discuss product-specific private-label development and document availability, contact us; the EU RP and qualified assessor retain their respective decisions.
Regulatory requirements may change. Brands should verify current requirements with the relevant regulatory authority or a qualified compliance professional before placing cosmetic products on the market.